
    
      A prospective, randomized, single-blind (blinded Independent Reviewer), intra-patient
      controlled, multicenter post-market study with 80 randomized subjects at up to 15 study
      centers.

      After successful in-office bilateral balloon dilation of the frontal sinus ostium (FSO) using
      the VenSureâ„¢ Nav Balloon Device and Fiagon Cube Navigation System, patients will be
      randomized to receive one PROPEL Contour Sinus Implant on one side while the contralateral
      side serves as the control.
    
  